Everolimus is an anti-cancer medication classified as a kinase inhibitor, primarily used to treat various cancers, including breast, pancreatic, and renal cancers. It works by inhibiting the mTOR pathway, which is crucial for cell growth and proliferation. By blocking this pathway, Everolimus effectively slows down the growth of cancer cells and can also prevent organ rejection in transplant patients. In summary, Everolimus is a vital therapeutic agent in oncology and transplant medicine.
Everolimus inhibits the mammalian target of rapamycin (mTOR), disrupting cell cycle progression and inhibiting tumor cell proliferation.
No published brands for this salt yet.